CD8A and breast cancer: In a large study of 12,439 patients, assessment of T cell infiltration in breast cancer indicated that intratumoral CD8+ lymphocytes were associated with worse outcomes in HR+/HER2- patients, however the association did not remain significant in multivariate analysis (35).